Site Search

Development of COVID-19 vaccine
Development of nanoparticle-based dengue DNA vaccine
We have been working on HIV DNA vaccine
HDM Allergy
Development of vaccines for prevention and treatment of HDM allergy
Development of subunit vaccines against leptospirosis

Center of Excellence in Vaccine Research and Development,
Chulalongkorn University (Chula VRC)

Chula VRC was formally established in 2017 under the supervision of Professor Kiat Ruxrungtham. We consists of faculty staff and researchers with common interest in vaccine research and development to work together and share their knowledge and experience leading to the strength of the team. We focuses not only on vaccines against infectious diseases, such as HIV infection, dengue fever, leptospirosis, and emerging infections including novel corona virus disease (COVID-19) but also vaccines against non-infectious diseases including house dust mite allergy.

We are Chula VRC

Dengue Team

HIV Team

House Dust Mite Team

Leptospirosis Team

COVID-19 Team

Key Contact Persons

Latest News & Events

July 8, 2021
Prof Kiat Ruxrungtham from the Center of Excellence in Vaccine Research Center and Development. Photo courtesy of Chulalongkorn Hospital
July 7, 2021

Kiat Ruxrungtham isn’t content to see Thailand wait in line to buy vaccines from another country.

July 6, 2021

The first phase of clinical trial on volunteers who have passed the screening process and deemed to be in good health

Posted in News | Tags: ,
July 2, 2021

Thailand is tightening border controls as the country faces its worst coronavirus outbreak.

July 2, 2021

Chulalongkorn University’s mRNA Covid-19 vaccine, ChulaCov19, began its first round of human trials

July 2, 2021

Thailand has begun human trials with two of four homegrown vaccine

Posted in News | Tags: